Pseudoamide-Type Pyrrolidine and Pyrrolizidine Glycomimetics and Their Inhibitory Activities against Glycosidases

Journal of Organic Chemistry

Volumn 69, Issue 10, 2004, Pages 3578-3581

  García Moreno, M Isabel ^a   Rodríguez Lucena, David ^a   Ortiz Mellet, Carmen ^a   García Fernández, José M ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b INSTITUTO DE INVESTIGACIONES QUÍMICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITION; ENZYMES; GLYCOLS; UREA;

COUPLING REACTIONS; ISOTHIOCYANATES; PYRROLIZIDINE GLYCOMIMETICS; THIOUREAS;

NITROGEN COMPOUNDS;

3,4 DIHYDROXY 2,5 BIS(HYDROXYMETHYL)PYRROLIDINE; CARBAMIC ACID DERIVATIVE; GLYCOSIDASE; ISOTHIOCYANIC ACID DERIVATIVE; PYRROLIDINE DERIVATIVE; PYRROLIZIDINE DERIVATIVE; THIOCARBAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBONYLATION; ENZYME INHIBITOR INTERACTION; INHIBITION KINETICS; MOLECULAR DYNAMICS; REACTION ANALYSIS; SYNTHESIS;

AMIDES; CARBOHYDRATE CONFORMATION; ENZYME INHIBITORS; GLYCOSIDE HYDROLASES; PYRROLIDINES; PYRROLIZIDINE ALKALOIDS;

EID: 3242796921     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0499221     Document Type: Article

References (48)

1. For recent leading reviews, see: (a) N. Asano, N. Glycobiology 2003, 13, 93R.
2. (b) Greimel, P.; Spreitz, J.; Stütz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003, 3, 513.
3. (c) Butters, T. M.; Dwek, R. A.; Platt, F. M. Curr. Top. Med. Chem. 2003, 3, 561.
4. (d) Vasella, A.; Davies, G. J.; Böhm, M. Curr. Opin. Chem. Biol. 2002, 6, 619.
5. (e) Heightman, T. D.; Vasella, A. Angew. Chem., Int. Ed. 1999, 38, 750.
6. (f) Sears, P.; Wong, C.-H. Chem. Commun. 1998, 1161.
7. (g) Dwek, R. A. Chem. Rev. 1996, 96, 683.
8. Although the term "azasugar" is widely used in the literature to refer to glycomimetics where the endocyclic oxygen atom has been replaced by nitrogen, the term is not strictly correct according to the IUPAC-IUMB nomenclature recommendations for carbohydrates, the accepted term being "iminosugar". "Azahexose" would actually imply that a carbon atom has been exchanged for a nitrogen atom. See: McNaught, A. D. Pure Appl. Chem. 1996, 68, 1919.
9. For recent reviews on iminosugar glycosidase inhibitors, see: (a) Asano, N. Curr. Top. Med. Chem. 2003, 3, 471.
10. (b) Lillelund, V. H.; Jensen, H. H.; Liang, X.; Bols, M. Chem. Rev. 2002, 102, 515.
11. (c) Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochemistry 2001, 56, 265.
12. (d) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645.
13. (e) Elbein, A. D.; Molyneux, R. J. Alkaloid Glycosidase Inhibitors. In Comprehensive Natural Products Chemistry; Barton, D., Nakanishi, K., Meth-Cohn, O., Eds.; Elsevier: Oxford, 1999; Vol. 3, p 129.
14. (f) Simmonds, M. S. J.; Kite, G. C.; Porter, E. A. Taxonomic Distribution of Iminosugars in Plants and Their Biological Activities. In Iminosugars as Glycosidase Inhibitors; Stütz, A., Ed.; Wiley-VCH: Weinheim, Germany, 1999; p 8.
15. (g) Ossor, A.; Elbein, A. D. Glycoprotein Processing Inhibitors. In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinaÿ, P., Eds.; Wiley-VCH: Weinheim, Germany, 2000; Part II, Vol. 3, p 513.
16. (a) Martin, O. R. Toward Azaglycosyl Compounds and Homoazaglycosides. In Carbohydrate Mimics. Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, Germany, 1998; p 259.
17. (b) Wong, C.-H-; Provencher, L.; Porco, J. A., Jr.; Jung, S.-H.; Wang, Y.-F.; Chen, L.; Wang, R.; Steensma, D. H. J. Org. Chem. 1995, 60, 1492.
18. Evans, S. V.; Fellows, L. E.; Shing, T. K. M.; Fleet, G. W. J. Phytochemistry 1985, 24, 1953.
19. (a) Molyneux, R. J.; Benson, M.; Wong, R. Y.; Tropea, J. E.; Elbein, A. D. J. Nat. Prod. 1988, 51, 1198-1206.
20. (b) Kato, A.; Kano, E.; Adachi, I.; Molyneux, R. J.; Watson, A. A.; Nash, R. J.; Fleet, G. W. J.; Wormald, M. R.; Kizu, H.; Ikeda, K.; Asano, N. Tetrahedron: Asymmetry 2003, 14, 325.
21. van den Broek, L. A. G. M. Azasugars: Chemistry and Their Biological Activity as Potential Anti-HIV Drugs. In Carbohydrates in Drug Design; Witczak, Z. J., Nieforth, K. A., Eds.; Marcel Dekker: New York, 1997; p 471.
22. 2 character, typically a pseudoamide-type nitrogen.
23. (a) García-Moreno, M. I.; Benito, J. M.; Ortiz Mellet, C.; García Fernández, J. M. J. Org. Chem. 2001, 66, 7604.
24. (b) Díaz Pérez, V. M.; García-Moreno, M. I.; Ortiz Mellet, C.; Fuentes, J.; García Fernández, J. M.; Díaz Arribas, J. C.; Cañada, F. J. J. Org. Chem. 2000, 65, 136.
25. (c) Jiménez Blanco, J. L.; Diaz Pérez, V. M.; Ortiz Mellet, C.; Fuentes, J.; García Fernández, J. M.; Díaz Arribas, J. C.; Cañada, F. J. Chem. Commun. 1997, 1969.
26. For reviews on trehazolin and close analogues ("trehazoloids"), see: (a) Berecibar, A.; Grandjean C.; Siriwardena, A. Chem. Rev. 1999, 99, 779.
27. (b) Kobayashi, Y. Carbohydr. Res. 1999, 315, 3.
28. For recent reports on combinatorial synthetic strategies applied to the identification of selctive glycosidase inhibitors in the pyrrolidine azasugar series, see: (a) Gerber-Lemaire, S.; Popowycz, F.; Rodríguez-Garcí a, E.; Carmona Asenjo, A. T.; Robina, I.; Vogel, P. ChemBioChem 2002, 3, 466.
29. (b) Saotome, C.; Wong, C.-H.; Kanie, O. Chem. Biol. 2001, 8, 1061-1070.
30. (c) Takebayashi, M.; Hiranuma, S.; Kanie, Y.; Kajimoto, T.; Kanie, O.; Wong, C.-H. J. Org. Chem. 1999, 64, 5280.
31. Tatibouët, A.; Lefoix, M.; Nadolny, J.; Martin, O. R.; Rollin, P.; Yang, J.; Holman, G. D. Carbohydr. Res. 2001, 333, 327.
32. 5-Azido-5-deoxy-D-fructopyranose derivatives have also been obtained from L-sorbose, an alternative starting material for DMDP synthesis; see: (a) Murphy, D. J. Chem. Soc. C 1967, 1732.
33. (b) Kuzuhara, H.; Emoto, S. Tetrahedron Lett. 1973, 14, 5051.
34. For alternative recent syntheses of DMDP, see: (a) Donohoe, T. J.; Headley, C. E.; Cousins, R. P. C.; Cowley, A. Org. Lett. 2003, 5, 999.
35. (b) Dondoni, A.; Giovannini, P. P.; Perrone, D. J. Org. Chem. 2002, 67, 7003.
36. (c) Izquierdo, I.; Plaza, M. T.; Franco, F. Tetrahedron: Asymmetry 2002, 13, 1503.
37. (d) Le merrer, Y.; Poitout, L.; Depezay, J.-C.; Dosbaa, I.; Geoffroy, S. ; Foglietti, M.-J. Bioorg. Med. Chem. 1997, 5, 519.
38. (a) García-Moreno, M. I.; Díaz Pérez, P.; Ortiz Mellet, C.; García, Fernández, J. M. J. Org. Chem. 2003, 68, 8890.
39. (b) García-Moreno, M. I.; Díaz Pérez, P.; Ortiz Mellet, C.; García Fernández, J. M. Chem. Commun. 2002, 848.
40. Camarasa, M. J.; Fernández-Resa, P.; Garcia-López, M. T.; de las Heras, F. G.; Méndez-Castrillón, P. P.; San Félix, A. Synthesis 1984, 509.
41. For a discussion of the structural properties and reactivity of sugar thioureas, see: Ortiz Mellet, C.; García Fernández, J. M. Adv. Carbohydr. Chem. Biochem. 1999, 55, 35.
42. Ekhart, C. W.; Fechter, M. H.; Hadwiger, P.; Mlaker, E.; Stütz, A. E.; Tauss, A., Wrodnigg, T. M. Tables of Glycosidase Inhibitors with Nitrogen in the Sugar Ring and Their Inhibitory Activities. In Iminosugars as Glycosidase Inhibitors; Stütz, A., Ed.; Wiley-VCH: Weinheim, Germany, 1999; p 253.
43. Theoretical and experimental studies indicate that true transition state analogues must be essentially neutral or zwitterionic at physiological pH to keep specificity against the target enzyme. See: (a) Legler, G. Glycosidase Inhibition by Basic Sugar Analogues and the Transition State of Enzymatic Glycoside Hydrolysis. In Iminosugars as Glycosidase Inhibitors; Stütz, A., Ed.; Wiley-VCH: Weinheim, 1999; p 31
44. (b) Jeong, J.-H.; Murray, B. W.; Takayama, S.; Wong, C.-H. J. Am. Chem. Soc. 1996, 118, 4227.
45. (c) Legler, G.; Finken, M.-T. Carbohydr. Res. 1996, 292, 103.
46. (d) Blériot, Y.; Genre-Grandpierre, A.; Imberty, A.; Tellier, C. J. Carbohydr. Chem. 1996, 15, 985.
47. (e) Deng, H.; Chan, A. W.-Y.; Bagdasianan, C. K.; Estupiñán, B.; Ganem, B.; Callender, R. H.; Scharamm, V. L. Biochemistry 1996, 35, 6037.
48. (f) Ernert, P.; Vasella, A.; Weber, M.; Rupitz, K.; Withers, S. G. Carbohydr. Res. 1993, 250, 113.